MARKET

SNY

SNY

Sanofi FR
NASDAQ
47.73
-0.45
-0.93%
After Hours: 47.73 0 0.00% 17:14 04/01 EDT
OPEN
47.91
PREV CLOSE
48.18
HIGH
48.22
LOW
47.66
VOLUME
2.59M
TURNOVER
--
52 WEEK HIGH
53.42
52 WEEK LOW
43.32
MARKET CAP
115.27B
P/E (TTM)
12.76
1D
5D
1M
3M
1Y
5Y
1D
Aventis Energy files NI 43-101 technical report for Sting Copper project in Newfoundland and Labrador
Reuters · 12h ago
Sanofi (SNYNF) Gets a Hold from Kepler Capital
TipRanks · 23h ago
Sanofi Builds Immunology Momentum with March 2026 Wave of Global Approvals and Data
TipRanks · 1d ago
Is Trump to blame for delayed drug launches in Europe
Seeking Alpha · 1d ago
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
TipRanks · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)
TipRanks · 1d ago
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
TipRanks · 1d ago
Sanofi Receives EU Conditional Marketing Authorization For Rezurock In Chronic GVHD
NASDAQ · 1d ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.